FOXO3 and idiopathic pulmonary fibrosis: Employing UCN‐01 to activate FoxO3 in lung fibrosis, this agent was found to inhibit proliferation of IPF fibroblasts as well as donor fibroblasts that were stimulated by FCS, PDGF‐BB, or IGF‐1.